Paula da Costa Martins

Associate professor

Dr Paula da Costa Martins has graduated in Biology at the Faculty of Sciences, University of Lisbon, in Portugal. Afterwards, she moved to Amsterdam, in the Netherlands, to work on cellular and molecular biology, focussing on the interactions between immune and endothelial cells, and their contribution to inflammation and atherosclerosis, at Sanquin Research, and for which she obtained her PhD at the University of Amsterdam. Subsequently, she followed her post-doctoral research at the Hubrecht Institute (Utrecht, The Netherlands), studying the contribution of noncoding RNAs in the onset and development of heart disease.

She has been working at Maastricht University since 2010. The focus of her research is deciphering the contribution of non-coding RNAs, specially microRNAs, to the development and progression of cardiac disease. More specifically, she centres her research on understanding how different cardiac cell types communicate to influence each other’s phenotype and in a concerted manner contribute to pathologic cardiac remodelling. Her main interest is unveiling how cardiomyocytes send 'microRNA messages’ to cardiac endothelial cells and inflammatory cells via exosomes, to alter their angiogenic and inflammatory properties, respectively. In this way she expects to identify new gene targets or processes where one can intervene to prevent or cure heart disease.

Department of Cardiology
Department of Molecular Biology and RNA Technology 
Universiteitsingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
T: +31 (0)43 388 22 22

  • 2012
    • van Empel, V. P. M., De Windt, L. J., & Martins, P. A. D. C. (2012). Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease?Current Hypertension Reports, 14(6), 498-509. https://doi.org/10.1007/s11906-012-0310-7
    • el Azzouzi, H., Leptidis, S., Bourajjaj, M., van Bilsen, M., Martins, P. A. D. C., & De Windt, L. J. (2012). MEK1 Inhibits Cardiac PPAR alpha Activity by Direct Interaction and Prevents Its Nuclear Localization. PLOS ONE, 7(6), Article e36799. https://doi.org/10.1371/journal.pone.0036799
    • Martins, P. A. D. C., & De Windt, L. J. (2012). MicroRNAs in control of cardiac hypertrophy. Cardiovascular Research, 93(4), 563-572. https://doi.org/10.1093/cvr/cvs013
    • Gladka, M. M., Martins, P. A. D. C., & de Windt, L. J. (2012). Small changes can make a big difference - MicroRNA regulation of cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 52(1), 74-82. https://doi.org/10.1016/j.yjmcc.2011.09.015
  • 2011
    • el Azzouzi, H., Leptidis, S., Bourajjaj, M., Armand, A.-S., van der Nagel, R., van Bilsen, M., Martins, P. A. D. C., & De Windt, L. J. (2011). Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPAR alpha Target Gene in Cardioprotection. Journal of Biological Chemistry, 286(16), 14598-14607. https://doi.org/10.1074/jbc.M111.220525
  • 2010
    • Martins, P. A. D. C., Salic, K., Gladka, M. M., Armand, A.-S., Leptidis, S., el Azzouzit, H., Hansen, A., Coenen-de Roo, C. J., Bierhuizen, M. F. A., van der Nagel, R., van Kuik, J., de Weger, R. A., de Bruin, A., Condorelli, G., Arbones, M. L., Eschenhagen, T., & De Windt, L. J. (2010). MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nature Cell Biology, 12(12), 1220-U231. https://doi.org/10.1038/ncb2126
    • Martins, P. A. D. C., Leptidis, S., Salic, K., & De Windt, L. J. (2010). MicroRNA Regulation in Cardiovascular Disease. Current Drug Targets, 11(8), 900-906. https://doi.org/10.2174/138945010791591322